The Nike ZoomX Zegama Trail 2 is a surprisingly lightweight trail running shoe that’s perfect for running on rocky terrain ...

Nike’s $140 Pegasus 41 running shoes are now just $70. Shoppers say they’re “comfortable and supportive,” making them a great ...

After a period of shareholder panic, the brand has unveiled four new innovations to prove that it’s still pioneering the ...

Nike’s favorite skateboarding shoe is getting a makeover. The Nike SB Dunk Low Pro Persian Violet and Off Noir drops Tuesday, Oct. 7, at 10 a.m. ET for $120 a pair. While the shoes still have their ...

From snow-covered mountain trails to slushy city sidewalks, winter running shoes will protect your feet and keep you upright ...

Personal trainers and editors tested more than two dozen of the best cross-training shoes for women during cardio and ...

Nike designers now work under the mantra “Create epic s-t.” That language sets the tone: it isn’t about incremental tweaks, ...

We even found markdowns so cheap we were surprised to see them. You can grab this men’s K-Swiss Proto Trainer sneaker for only $45. Just add it to your cart and you’ll see the price drop. These are ...

The LeBron 23 ‘Stocking Stuffer’ brings holiday flair to the court. Get the release date, details, and what makes this the ...

Among megacap stocks, Nvidia dropped 0.9%, Meta Platforms shed 2.8%, and Alphabet lost 1.1%. Healthcare stocks gained with Moderna and Regeneron both surging more than 6.3%.

On Holding (ONON) is upgraded from 'sell' to 'hold' after a 20% stock correction, but shares remain too expensive for a buy.